los Huesos ('Pit of the bones'), which is where most of the fossils with claimed Neanderthal affinities come from. The more than 6000 fossils from that site show distinctive Neanderthal features, but have often been included in the H. heidelbergensis taxon because of their supposed great age (up to 600 ka). Further research has now suggested that the material looks too Neanderthal and is too young (~400 ka) to represent H. heidelbergensis, making these fossils early Neanderthals instead. However, adding extra complexity, recent findings reveal the Sima people's mitochondrial DNA to be more similar to that of the Denisovans (see below) than Neanderthals.
Are they our ancestors? African H. heidelbergensis material, such as Broken Hill, shares numerous features with European fossils such as Petralona, leading many to group them together. As long as Mauer is also included, this taxon can be named H. heidelbergensis. Proponents of this wide concept of H. heidelbergensis assert that the mosaic of primitive and derived features shared by this group of fossils is unique, with few traits linking them exclusively to either modern humans or Neanderthals ( Figure 1B ). H. heidelbergensis is thus hypothesised to be the last common ancestor of both Neanderthals in Eurasia and H. sapiens in Africa. This scenario is probably the most popular and well supported at present.
Why does it matter?
Modern humans and Neanderthals show clear behavioural and morphological differences from each other, but also clear similarities. Determining the tempo and mode of the evolution of their distinct features requires an estimate for the divergence date of their lineages from the last common ancestor, while assessing the extent of behavioural and morphological features that may have evolved in parallel (e.g. burial of the dead, neurocranial expansion) requires knowledge of those features in the LCA. As yet, no H. heidelbergensis DNA has been sequenced, so the species cannot be recognised genetically, but by comparing genetic data from Neanderthals and H. sapiens it is possible to estimate a hypothetical divergence date (~410-440 ka) for the two species, based on mitochondrial DNA, providing calibration for the putative transition from H. heidelbergensis to its daughter species. If we know when and where we diverged from our closest relatives, we also have a better chance of inferring the selective pressures behind the origin of our species, finding out why populations of H. heidelbergensis separated and evolved into H. sapiens and Neanderthals.
You mentioned Denisovans. Could they be H. heidelbergensis or its descendants? In 2010, DNA sequenced from a fossil finger bone in Siberia showed the existence of an unexpected additional human population in the late Pleistocene. This group was christened the 'Denisovans' after the site of Denisova Cave. We still don't know what the Denisovans looked like, or completely understand their position relative to other species, but genomic data suggest they are related to the Neanderthals ( Figure 1A,B) . However, evidence of interbreeding with recent H. sapiens in Southeast Asia shows that the Denisovans were once widespread in the region. As there are potential H. heidelbergensis fossils from Asia, it is possible they could represent the ancestors of the Denisovans. Recent advances in ancient DNA extraction and processing mean that recovering diagnostic genetic material from mid-Pleistocene fossils such as the remains from Asia is now an exciting possibility. The geographic origin of H. heidelbergensis is still unknown, but the early fossils from Asia suggest that continent is as likely a place of origin as Europe or Africa at the moment. An Asian origin for a species directly ancestral to our own would certainly shake up the current rather Afro-centric view of our evolution.
Where can I find out more? Harvati, K. (2007) . 100 years of Homo heidelbergensis -life and times of a controversial taxon. Mitteilungen der Gesellschaft für Urgeschichte. 16, 85-94. Mounier, A., Marchal, F., and Condemi, S. (2009) Ubiquitin is produced by four distinct genes: two of these, UBA52 and RPS27a, encode a single copy fused to ribosomal subunits, whereas the other two, UbB and UbC, are polyubiquitin genes encoding three and nine headto-tail repeats of ubiquitin, respectively. Free ubiquitin is cleaved from these gene products by peptidases that belong to the deubiquitylating family of enzymes (DUBs). UbC may make the major contribution to steady levels of ubiquitin, given that murine embryonic fibroblasts lacking Ubc have 40% lower levels of ubiquitin, despite compensatory upregulation of the UbB transcript. Total ubiquitin levels in human embryonic kidney HEK293 cells have been estimated as 8 x 10 7 copies per cell (85 µM, 0.42% w/w protein), with 'free' ubiquitin being a fraction (23%) of this pool.
Ubiquitylation principally occurs at lysine residues of substrate proteins, creating an isopeptide bond. Monoubiquitylation accounts for the majority of substrate-conjugated ubiquitin in HEK293 cells (~63% of the total ubiquitin pool, of which about half is present in a histone-enriched fraction; Figure 1A ). However, ubiquitin itself contains seven internal lysine residues -at positions 6, 11, 27, 29, 33, 48, 63 -that allow for chains of ubiquitin to be formed by processive ubiquitylation events (~11% of the total ubiquitin pool in HEK293 cells). The Primer representation of these individual chain types can vary significantly between cell types and species ( Figure 1A) .
A dedicated apparatus also exists to generate linear chains of ubiquitin linked through peptide bonds between the amino and carboxyl termini of neighbouring ubiquitins. Polyubiquitin chains may be constituted from a single linkage type or from a mixture of linkages, which allows for chain branching. The relative abundance of each chain linkage type has been determined by mass spectrometry, through quantifying specific trypsingenerated peptide signatures ( Figure  1B ,C). Linkages through these different lysine residues vary the disposition of neighboring ubiquitin molecules with respect to each other, thereby offering specific combinations of available surfaces and orientations. This property is exploited by processing enzymes and by ubiquitin-binding proteins to obtain selectivity for particular linkage types. Thus, distinct chain types have been linked to specific steps in the choreography of complex cellular processes, such as cell-cycle regulation (Lys11) and DNA repair (Lys63). However, all chain linkages, with the probable exception of Lys63, may contribute to the proteasomal turnover of proteins, as judged by their pattern of accumulation upon proteasome inhibition and in vitro studies. Ubiquitylation resembles phosphorylation in scope, but glycosylation in complexity.
Generating the code on substrate proteins Ubiquitylation results from an enzymatic cascade, drawn from a palette of enzymes with a distinct hierarchy: E1s (two family members, UBA1 and UBA6 in the human genome); E2s (~40 members); and >600 E3s, which belong to one of three families (HECT, RING and RINGbetween-RING (RBR)). A small set of E3 RING proteins combine with any of seven cullin family members and a variety of adaptor proteins to create a diverse family of cullin-E3 ligases. Recent proteomic studies, using an antibody that recognises diGly-modified Lys residues to enrich ubiquitylated peptides, confirm the presence of many thousands of ubiquitylated proteins in the cell at steady state ( Figure 2 ).
E1s utilise a sequence of reactions driven by ATP to generate a thioester linkage between the carboxyl terminus of ubiquitin and the E1 active-site cysteine ( Figure 3A) . A key feature is the generation of a ubiquitin carboxyterminal acyl-adenylate intermediate (Ub-AMP), which reacts with the cysteine. Subsequently, a second Ub-AMP is generated, which remains non-covalently bound to the enzyme and enhances efficiency. Structural rearrangements increase the affinity for E2 enzymes, facilitating ubiquitin transfer to the E2 active-site cysteine by a trans-thioesterification reaction. were able to apply mass spectrometry to measure their relative sizes. Note that 'free' ubiquitin measured in these studies also includes activated ubiquitin (thioester-linked), which is typically 30-50% of the total 'free' pool. Using the approach indicated in (C), Peng and colleagues have obtained estimates of the prevalence of particular ubiquitin chain Lys-linkage types within the polyubiquitin fraction in (ii) HEK293 and (iii) Saccharomyces cerevisiae (using cells expressing His-tagged Ub). (B) Eight varieties of ubiquitin chain linkages, with distinct topologies, occur within the cell. Seven of these are linked through isopeptide bonds between the carboxyl terminus and specific lysine (K) residues on ubiquitin. The other is a linear ubiquitin chain, which is linked through a peptide bond with the amino-terminal methionine (M1). (C) Trypsin cleaves carboxy-terminally to basic residues, and the last four residues of ubiquitin are Leu-Arg-Gly-Gly. Digestion of ubiquitin chains with trypsin therefore generates a diGly carboxy-terminal remnant linked through an isopeptide bond to a linear peptide sequence, specific to the flanking sequences of each lysine in ubiquitin. These peptides are quantified by mass spectrometry using comparison with isotopically labelled peptide standards (Absolute QUAntification (AQUA) peptides), which are spiked into the sample. This technique has been used to generate the data shown in (Aii) and (Aiii). (D) Chain-linkage types that are appended to individual proteins of interest can be assessed using a ubiquitin chain restriction digest. Immunoblotting using anti-ubiquitin antibodies reveals changes in the higher molecular weight smear or ladder above the parental protein, which represents the polyubiquitylated forms. The collapse of this ladder is analysed following exposure to a panel of DUB enzymes (here Otulin, AMSH, OTUB-1 and USP21) that have activities specific for different chain types.
HECT and RBR E3s also possess an active-site cysteine, which is charged with ubiquitin that has been transferred from their cognate E2 enzyme, prior to substrate modification. A significant fraction of the so-called 'free' ubiquitin pool (30-50%) is in fact thioester-linked to ubiquitin ligases at steady state. This can be quantified by comparing the low molecular weight ubiquitin band on gels run under reducing and nonreducing conditions. RING E3 ligases, lacking a catalytic cysteine, represent the most abundant set of E3s and instead serve as scaffold molecules, which also help align the E2-ubiquitin thioester bond for attack by the substrate lysine. The cullin E3 ligases are only activated following NEDDylation (modification with the ubiquitin-like molecule NEDD8) of the cullin subunit. This results in a dramatic reorientation of the RING domain, bringing the associated E2 adjacent to the substrate site. Largescale conformational changes are also intrinsic to HECT ligase function and to the regulation of certain RING proteins, such as c-Cbl. Both E2s and E3s have active roles in determining the chain topology -i.e. linkage type -and processivity of chain elongation.
Ubiquitin chain formation can be broken down into two key steps: firstly, initiation via conjugation to the substrate of the first ubiquitin; and secondly, chain elongation. After ubiquitin is discharged from the E2, the E2 must dissociate from the E3 in order to be recharged with ubiquitin by an E1. This frequently results in simple monoubiquitylation of substrates.
However, if the chain is to be extended, either the original charged E2-E3 combination can be reconstituted or an alternative E2 can be recruited that specialises in this task and may restrict the repertoire of linkage types. For example, the Lys63-and Lys11-specific chain-elongating E2s, UBE2N-UBE2V1 and UBE2S, respectively, are unable to initiate ubiquitin chains. The Lys11 selectivity of UBE2S depends upon a specific substrate-assisted catalysis mechanism. Alignment of the active site with Lys11 of the acceptor ubiquitin, through transient electrostatic interactions, brings Glu34 of ubiquitin close to the E2 catalytic site, completing a competent catalytic centre.
As well as linkage type, chain length is another parameter that can be interpreted by cellular machineries. Chain length reflects the processivity of the reaction, defined as the number of ubiquitin molecules transferred during a single round of association of an E3 ligase with a substrate. Early in vitro studies suggested that a minimal length of four Lys48-linked ubiquitin molecules is required for proteasomal degradation, and three Lys63-linked ubiquitin molecules are required for the efficient activation of retinoic acid inducible gene 1 (RIG1), a component of the innate immunity system.
Reading the code
The concept of conserved ubiquitinbinding domains (UBDs) was introduced by the discovery of the UBA domain in multiple proteins that had been linked to ubiquitylation, including the multifunctional protein p62, for which actual binding to ubiquitin was first demonstrated. There are now at least 20 recognised UBDs in the human genome contained within hundreds of proteins. This realisation has led to the appreciation of ubiquitylation as a critical means of regulating the formation of networks of protein interactions and the activity of these networks in space and time ( Figure  3B ). Pioneering studies on the NFkB and DNA repair pathways implicated ubiquitin at the heart of these signaling cascades, and this finding is now mirrored in studies of further key signaling pathways (e.g. TGFb, Wnt, MAP kinase).
Ubiquitin has a hydrophobic patch centred around Ile44 which is recognised by the majority of ubiquitin-binding domains. However, other modes of binding have been characterised. For example, the ZnF-UBP domain, found in the DUB USP5, principally recognises the diGly carboxyl terminus of unanchored ubiquitin, and the UBAN motif of NFkB essential modulator (NEMO) requires an interaction with the linker region of Met1-linked linear ubiquitin chains. The affinity of UBDs for monoubiquitin is necessarily low (>100 µM) as 'free' ubiquitin itself is estimated to be in the 10-20 µM range. Avidity will be correspondingly higher for ubiquitin chains, due to the multiplicative effect of more than one binding site. According to the published structures, one might predict different levels of access to more compact ubiquitin chain configurations (e.g. Lys48) versus open structures (Lys63). However, some Total cell lysate
Incubation with anti-di-Gly antibody Figure 2 . Enrichment of diGly-modified peptides allows global ubiquitome profiling. Trypsin digestion of complex protein mixtures will leave a diGly stump of the distal ubiquitin molecule, linked through an isopeptide bond to the lysine residue of any ubiquitylated peptide sequence. Introduction of monoclonal antibodies specific for this configuration of three amino acids has provided an enrichment strategy for ubiquitylated peptides and has allowed for the identification of thousands of ubiquitylated peptides by mass spectrometry.
types of ubiquitin chain are clearly in dynamic equilibrium between 'open' and 'closed' structures and can be stabilised in the open configuration by UBD binding. It seems most likely that the combinatorial use of UBDs dictates many aspects of ubiquitin chain specificity. Frequently, proteins possess tandem UBDs, allowing for 'linkage-specific avidity' that relies on the detection of the distance between the individual molecules of a ubiquitin chain and the orientation of these molecules ( Figure 3B ). The DNA repair protein, Rap80 has tandem UIM domains separated by a seven amino-acid linker region, which creates the ideal distance for association with ubiquitin molecules spanning a Lys63 linkage. A shorter linker between UIMs in ataxin-3 provides binding specificity for Lys48 linkages. Associations between UBD-containing proteins may provide even more versatility. For example, the ESCRT-0 complex comprising Hrs and STAM, which is involved in endosomal sorting of ubiquitylated receptors, presents five ubiquitin-binding sites on its surface. Multi-monoubiquitylated protein modules present similar opportunities for discrimination. Ubiquitylated proteins can also receive contemporaneous post-translational modifications, such as phosphorylation or acetylation. Binding can therefore be contingent on two signals, sometimes referred to as coincidence detection. Understanding the cross-talk between these types of signal is a rapidly expanding area.
One role of the interaction of UBDs with ubiquitin chains is to protect proteins from proteasomal degradation, and this may underly the privileged protection of Lys63 chains. An interesting case is the yeast transcription factor Met4, which contains two UBDs that stabilise it in a Lys48-linked form, but restrict the linear growth of the polyubiquitin chain. Under certain growth conditions, this protection is removed and rapid chain (A) The ubiquitylation cascade. An E1 is charged with ubiquitin (Ub) linked to the catalytic cysteine of E1 by a thioester bond. This leads to structural rearrangements that allow for association with E2 enzymes and the transfer of ubiquitin to E2. The charged E2 interacts with E3 ligases, which also recognise substrates. In the case of RING E3s, which simply act as scaffolds, ubiquitin is then directly transferred from the E2 to lysine residues on substrate proteins. For HECT and RING between RING (RBR) E3s, ubiquitin is transferred via the E3 itself following charging by the E2. Discharge of Ub from the E2 reduces the affinity of E2 for the E3, providing access for a newly charged E2 to extend a ubiquitin chain. The complement of ubiquitin-modifying components in the human genome has a hierarchical structure, with substrate specificity provided by a large number of E3s (bottom). (B) Ubiquitylation is recognised by around 20 types of ubiquitin-binding domain (UBD), which allow the assembly of ubiquitin-dependent interaction networks. Tandem arrangements of UBDs or associations between UBD proteins produce specific geometries that allow selection for ubiquitin chain types (a-d), or coincidence detection of multi-monoubiquitylation ((i) and (ii)). UBD binding can also shift the dynamic equilibrium between open and closed states of certain ubiquitin chain types (iii). (C) Deubiquitylases (DUBs) process ubiquitin chains. In addition to chain-type selectivity as shown in Figure 1D , some DUBs recognise different positions in the ubiquitin chain (exopeptidase and endopeptidase activity). Exopeptidase activity, specific to the distal ubiquitin, regenerates free ubiquitin directly, whilst endopeptidase activity can also release short ubiquitin chains. Specific removal of chains en bloc may require recognition of the substrate protein. Enzymes restricted to specific types of ubiquitin-chain linkage will generate a monoubiquitin stub, which can be removed by a more promiscuous enzyme or a substrate-selective DUB. extension promotes proteasomal degradation.
Editing and wiping the code
A set of ~90 DUBs can cleave the ubiquitin isopeptide bond at the end of a chain (exopeptidase activity) or from within the polymer (endopeptidase activity), as shown in Figure 3C . This set of DUBs contains five distinct families, four belonging to the cysteine protease class (UCH, USP, OTU and Josephins), and the other being the JAMM/MPN + family of metalloproteases. The cysteine proteases share a common catalytic triad (Cys-His-Asn/Asp), which must be properly aligned, in order to activate the cysteine for nucleophilic attack upon the peptide bond. Mirroring E2s, except with the opposite result, some DUBs will solely process specific chain linkages, such that they may edit the chain down to a monoubiquitylated stub, which a separate DUB may then cleave. Alternatively, the residual monoubiquitin may be extended once again either by the original or an alternative E2-E3 combination, which can lead to the generation of a new chain type at the same position (chain editing). It is common for DUBs and E3s to bind to each other, and the formation of such a complex may coordinate editing functions. Another view is that this reflects a separate major role of the DUBs: protecting E3s from their own tendency to autoubiquitylate and hence regulating their stability. An example of this is the association between USP7 and the p53 regulator MDM2.
The most abundant DUB family are the USPs and these also exhibit the greatest array of accessory domains, consistent with a higher degree of selectivity at the protein substrate level. Accordingly, with the exception of CYLD, USPs show little selectivity between linkage types when presented with free ubiquitin chains. In contrast, several of the JAMM/MPN + metalloproteases show stringent selectivity for Lys63-linked chains and have been implicated in the governance of endocytic trafficking (AMSH) and DNA repair (BRCC3) pathways. The OTU family is most fascinating from this point of view. Most OTUs prefer a restricted set of chain types, but the favored topologies vary greatly within the family: six of them are highly selective for an individual chain type, whilst a further four will cleave only two types of chain linkage. For example, three enzymes separately linked to the NFkB signaling pathway exclusively process in vitro either linear chains (Otulin), Lys11 chains (Cezanne) or Lys11 plus Lys48 (A20). These characteristics suggest that the OTUs may play prominent roles in chain editing and in regulating the global abundance of specific linkage types.
This refinement of DUB selectivity profiles underpins a novel method for the interrogation of chain linkages associated with particular proteins. By assessing the impact of a panel of selective DUB enzymes upon the higher molecular weight ubiquitin species, a 'restriction map' can be generated ( Figure 1D ). Only the minor ubiquitin chain linkage species Lys27, Lys29 and Lys33 cannot be discriminated in this manner with the current tool set.
Structural, biochemical and modeling studies of the action of DUBs upon various types of di-ubiquitin (diUb) have revealed a number of distinct mechanisms by which DUBs achieve chain selectivity. DUBs can interact with sites in ubiquitin that are both amino-terminal (P1, P2...) and carboxyterminal (P1', P2'....) to the scissile bond. The corresponding sites on the enzyme are referred to as S1 and S1' etc. The distal ubiquitin, which binds to the S1 site so that the carboxyterminal tail sits in the catalytic site, is common to all diUb molecules. Chain specificity must therefore reside in the recognition and alignment of the proximal ubiquitin. An S1' site specific to a restricted set of chain topologies can be provided by the catalytic domain of the DUB, or by an accessory UBD associated with the DUB itself (e.g. the UIM domain in OTUD1), or in principle by an interacting protein.
Each lysine of ubiquitin is flanked by different peptide sequences that could be used for selection. In general, OTUs do not discriminate between synthetic ubiquitylated-ubiquitin peptides, except for OTUD2, which is selective for peptides comprising the Lys11 flanking sequence. However, some DUBs that cleave either monoubiquitin or chains en bloc from protein substrates are likely to recognise the flanking regions.
The active-site histidine of the linearchain-specific DUB Otulin is misaligned for catalysis in the apo-enzyme. It is then aligned upon substrate binding, in part through interaction with the aminoterminal methionine of the proximal ubiquitin that is linked by a peptide bond to the carboxy-terminal glycine of the distal ubiquitin. The apo form of USP7 also has a misaligned active site. Correct positioning of the active site histidine is required to lower the pKa of the active-site cysteine rendering it competent for the nucleophilic attack on the ubiquitin-isopeptide bond, but this also makes DUBs vulnerable to oxidation. It follows then, that misalignment in the apo form provides a means to protect certain DUBs from oxidation.
Housekeeping roles for UCH DUBs
The UCH DUB family consists of four members -UCHL1, UCHL3, UCHL5 and BAP1. UCHL5 is a proteasomeassociated DUB, whilst BAP1 is a major tumor suppressor that has been associated with DNA repair pathways. UCHL1 and UCHL3 are intriguing members of the family that tend to be very highly expressed. For example, it has been estimated that UCHL1 may constitute as much as 2.5% of brain protein. At such levels its ubiquitin-binding capacity may provide an effective buffer of free ubiquitin concentration. The activity of these enzymes is restricted by an obstruction at the catalytic site to favour small leaving groups appended to the carboxyl terminus of ubiquitin. UCHs may be well suited for processing the pro-ubiquitin gene products, which in most organisms contain head-totail repeats of the ubiquitin sequence with an additional amino acid or short peptide capping the carboxyl terminus. All of the intermediates in the enzymatic activation of the ubiquitin carboxyl terminus are thioesters, which can form adventitious adducts by thiol or amine modification. In vitro data have led to the suggestion that, if left unchecked, this would rapidly deplete the free ubiquitin pool. Such adducts are processed efficiently by UCHL1/3 and this may represent the major physiological function of these particular DUBs.
Targeting the ubiquitin-proteasome system
There is a strong swell of interest in targeting the ubiquitin-proteasome system for therapeutic purposes. The proteasome inhibitor bortezomib has been used to treat tens of thousands of cancer patients. MLN-4924, an inhibitor that targets an E1 for the ubiquitin-like molecule NEDD8, also shows promise. Use of thalidomide as a treatment for multiple myeloma reflects its binding to cereblon, a component of a cullin In stark contrast to all known lurers, the bug did not strike its ant-prey when the prey was in close proximity, touching the bug, or even if the ant momentarily grasped the bug ( Figure 1C ; n = 1235 interactions). Instead, the bug only attacked when the ant firmly grasped a bug's hind leg and was either trying to sting or drag it (Supplemental movies). This trend remained even with the bugs at risk of starvation. Collected bugs starved for two weeks were placed in a 100 mm petri dish with an individual M. pilosula for 15 minutes. Even under these conditions the bugs still only attacked if an ant grasped a bug's hind leg (N = 95; n attacks/grasps = 18/18; n attacks/no grasps = 0/77; c 2 1 = 98.28; P << 0.001), and this was despite ants making numerous contacts with the bug prior to the attack (average = 38 ± 15 per trial). This departure from typical luring behaviour not only distinguishes feather-legged assasin bugs from other known lurers [5] [6] [7] [8] but also from all documented predators [1] . With an ant still grasping a leg, the bug then lifted its body off the tree trunk and swivels up to 180 o around its 'knee' joint to reposition its body above the ant. Here, the bug circumvented the hardened exoskeleton of the ant by piercing the indefensible intersegmental membrane just behind an ant's head.
Once an ant grasped a bug's hind leg, bugs had a surprisingly high capture success rate of 81% ( Figure  1B) . However, this crucial part of the prey capture strategy is also a major constraint ( Figure 1C) . Only 2.5% of bug-ant encounters resulted in ants grabbing a bug hind leg (n = 31 out of 1235 interactions), suggesting little return from this predatory strategy. The rarity of the capture events though is likely to be offset by prey size. Ants that physically interacted with the bugs were on average 1.93 ± 0.98 (n = 81) times larger than the bug. In some cases the size difference between the bug and ant was so large 
